Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Clinical Trials in the USA / NCT04124406
Active, not recruiting Observational

Voyage: Real-World Impact of the Multi-target Stool DNA Test on CRC Screening and Mortality

NCT04124406 · tracked via the Priya Life Science USA tracker
Sponsor
Exact Sciences Corporation
Phase
Observational
Started
2019-10-18
Last updated
2025-10-03

Condition(s) studied

Colon Cancer

Investigational drug(s) / intervention(s)

Cologuard

Cologuard: multi-target stool Deoxyribonucleic Acid (MT-sDNA) screening test

Study summary

The purpose of this study is to gather information about the long term health of people who have been prescribed the Cologuard test, which is used for colorectal cancer (CRC) screening.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Resident of the United States * Age 18 years or older * Able to provide informed consent * Able to complete surveys in English or Spanish * Valid order for Cologuard screening Exclusion Criteria: * N/A

Primary outcome measure(s)

  • Enrollment of Subjects — 3 years
    Enrollment of 150,000 subjects

Trial sites (1)

FacilityCityRegionStatus
Mayo Clinic Rochester Minnesota

More Exact Sciences Corporation trials in the USA

ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk Active, not recruiting
CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer Active, not recruiting
Falcon Real World Evidence Registry Recruiting
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD) Recruiting
Endometrial Cancer Vaginal Fluid Specimen Collection Study Active, not recruiting

Other trials for the same condition

A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors Active, not recruiting
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors Recruiting
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors Active, not recruiting
A Study of PHN-012 in Patients With Advanced Solid Tumors Recruiting
Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04124406 on ClinicalTrials.gov ↗ ← All trials in the USA